retatrutide efficacy clinical trials and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 retatrutide benefits clinical trials retatrutide

Steam or lightly cook greens to reduce volume and make eating larger amounts more practical

Foundayo is a once-daily pill classified as an oral small-molecule GLP-1 receptor agonist, with a different chemical structure from injectable GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), and from oral semaglutide (Rybelsus, the Wegovy pill), which belongs to the same peptide class as the injectables

A realistic UK approval window is late 2027 to mid 2028

Shelf-Stable Formula Vegan, non-GMO, gluten-free, dairy-free, and designed for stability without refrigeration

In a 2023 study, people taking 2.4 mg of semaglutide each week were nearly twice as likely to see NASH go away, without their liver scarring getting worse, compared to those on a placebo

Clin Ther (2012) 34:208290